CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,005 enrolled
Drug / intervention
Point-of-care STI testingother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05541081
NCT05541081N/ACompleted
CompareCT.gov

Investigating Point-of-care Diagnostics for Sexually Transmitted Infections and Antimicrobial Resistance in Primary Care in Zimbabwe

London School of Hygiene and Tropical Medicine·interventional·Posted Sep 15, 2022·Updated Sep 25, 2025

In Brief

A clinical study evaluating Point-of-care STI testing for Sexually Transmitted Infection and 8 related conditions. Completed, enrolled 1,005 participants across 1 site.

Detailed Summary

A prospective interventional study to evaluate a strategy of point-of-care testing for sexually transmitted infections including chlamydia, gonorrhoea, trichomoniasis, syphilis, and Hepatitis B with comprehensive case management including partner notification in antenatal settings in Harare province, Zimbabwe.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSexually Transmitted Infection, Chlamydia, Gonorrhea, Trichomoniasis, Syphilis, Hepatitis B, HIV Infections, Pregnancy, Sexually Transmitted Diseases
CountriesZimbabwe
CollaboratorsBiomedical Research and Training Institute

Timeline

N/ACompletedFinished
2023202420252026
First PostedSep 15, 2022
Enrollment StartJan 12, 2023
Primary CompletionOct 23, 2023
Study CompletionApr 29, 2024
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 3.8 years ago

Interventions

Point-of-care STI testingother

Testing for: * Chlamydia and gonorrhoea using the GeneXpert platform (Cepheid) * Trichomoniasis using the OSOM Trichomonas Rapid Test (Sekisui Diagnostics) * HIV and syphilis using the SD BIOLINE HIV/Syphilis Duo (Abbott Diagnostics Medical Co. Ltd) * Hepatitis B using the HBsAg2 rapid test (Abbott Diagnostics Medical Co. Ltd)